
Kevin Johnson
606 posts






Rivus Pharmaceuticals, a tiny biotech with seven full-time employees, says it has the preliminary data to suggest that its lead drug can play a big role in large indications like heart failure with preserved ejection fraction, type 2 diabetes and NASH. endpts.com/taking-on-big-…














Granular Therapeutics are excited to welcome @HarrisVitiligo Brian Kim and Romi Saini to our SAB. All three are KOLs in dermatology and mast cell driven disorders and have been helping to drive forward our unique strategy for selective mast cell targeting. granulartherapeutics.com

Amazing story! Congrats @_KateRyder @mavenclinic link.medium.com/MxEMMdHSRib


#NasdaqListed @centessa is a new kind of pharmaceutical company delivering asset centricity at scale. 🎉😍👏 Today, the $CNTA team rang the @Nasdaq Closing Bell in honor of their recent IPO. Congratulations!🛎️








